Invest in a basket, not a coin.

Half the weight in Bitcoin, half in tokenized real-world assets. ONDO holds tokenized US treasuries, SKY backs USDS partially with treasuries, PAXG anchors physical gold, CFG provides on-chain credit, POLYX runs the regulated security-token rail. A BTC-anchored construction that adds a yield-bearing RWA sleeve without diluting the core crypto position into mid-cap altcoins. For allocators who want Bitcoin exposure plus the RWA narrative in one ticker.

The full semiconductor stack from one basket. NVIDIA designs the GPUs, Broadcom and AMD build custom silicon, TSMC fabricates almost everything, ASML supplies the lithography machines that make fabrication possible, Arm licenses the underlying architecture, Qualcomm anchors edge compute. The thesis: AI inference and training capex remains a multi-year cycle, and every chip dollar passes through at least one of these companies.

Hand-picked from the highest-Sharpe assets in our 2-year backtest: NVIDIA (the largest contributor to the Semis 7 index's 2.30 Sharpe), Broadcom, Eli Lilly, gold, and a BTC/ETH crypto sleeve. Backtested Sharpe 1.54 over 729 days vs BTC's 0.15 in the same window. Total return +84.6%, max drawdown -24.6%, correlation to BTC -0.07. The Sharpe-maximised expression of cross-asset construction.

Geopolitical exposure as a defined thesis. Lockheed Martin for the multi-decade defense spending cycle. Vertiv for the data-center power and cooling infrastructure every hyperscaler is racing to build. MP Materials for the only US-domiciled rare-earth supply chain. Intel for the US semiconductor reshoring trade via CHIPS Act funding. All four are policy beneficiaries that trade small to mid-cap by US standards.

One layer beneath NVIDIA. Applied Materials and Lam Research sell the equipment that lets foundries make advanced chips. Arista Networks runs data-center networking at the hyperscalers. Marvell ships custom silicon for ASIC-bound workloads. Super Micro builds the servers Big Tech actually rolls into racks. Micron supplies the HBM memory that bottlenecks AI training. Higher beta than OSEM7, lower market cap per name.

Five-asset crypto construction with an embedded 25-delta BTC and ETH put hedge triggered when DVOL crosses the 70th percentile. BTC and ETH carry the directional thesis, SOL provides smart-contract leg, USDC absorbs the cash buffer, PAXG sits as the physical-gold hedge. The option overlay caps drawdown at the cost of a defined premium, which is the trade most crypto-native allocators cannot run themselves. Deribit options integration scheduled for H2 2026, until then the basket runs unhedged with the option layer flagged as forward-look.

Engineered for low BTC correlation while keeping Sharpe respectable. Heavy on US tech equity (NVIDIA, Microsoft, Apple) and gold for the de-correlation engine, with a 20% crypto sleeve (BTC + ETH) and a 10% broad-market ETF for upside participation. Backtested Sharpe 1.35 over 729 days, max drawdown -23% (less than half of BTC's -49% in the same window), correlation to BTC -0.07. The portfolio complement for an allocator who already holds BTC directly.

The five largest crypto assets by market capitalization, cap-weighted with 40% on Bitcoin. BTC and ETH provide about two thirds of the weight; SOL, BNB and XRP round out the smart-contract L1 set. The simplest one-decision exposure to the asset class, and the typical starting point for an institutional allocation.

The seven mega-cap technology leaders rebalanced daily on the after-hours print. After-hours liquidity captures earnings reactions, guidance updates and macro headlines that hit between 16:00 and 09:30 ET, the window where most single-name catalysts actually print. The 20% cap keeps NVIDIA from dominating after consecutive earnings beats. For allocators running tokenized equity exposure who want intraday-style responsiveness without leaving the basket wrapper.

Quality factor applied across asset classes. Microsoft, Broadcom and Eli Lilly are US blue-chips with durable cash flows. BTC and ETH for the crypto exposure. Gold for the macro hedge. SPY for the safety net. Backtested Sharpe 1.18 over 729 days, total return +49.5%, max drawdown -22.9%, correlation to BTC -0.08. The MSCI Quality analog for the on-chain era.

Bitcoin at 60% paired with a diversified large-cap crypto sleeve. ETH and SOL anchor the smart-contract leg, LINK covers the oracle layer, HBAR brings enterprise infrastructure, BNB and XRP add exchange and payments exposure, TRX rounds out the stablecoin-rail bet. A BTC-dominant construction that captures the rest of the top-tier crypto market without venturing into mid-caps. The institutional 'BTC plus a bit more' default.

Cross-asset balance designed as a single-decision allocation. BTC and ETH for crypto majors, NVIDIA and Apple for tech leadership, gold for the inflation hedge, SPY for broad equity. Backtested Sharpe 1.11 over 729 days, total return +48.9% versus BTC's +11.8% in the same window, max drawdown -24%. The 'one index does it all' starting point for an allocator who wants the asset-class spectrum in one ticker.

Real assets in ETF wrappers, settled on-chain. Gold via GLD and IAU (two issuers for tracking diversity), silver via SLV, oil via USO, palladium via PALL, rare-earth miners via REMX, copper miners via COPX. Inflation hedge plus the structural commodity tailwind from energy-transition demand. Roughly 40% of weight sits in precious metals.

Integrated oil and gas as a sovereign-risk hedge. Five super-majors with capex discipline, durable dividends, and exposure to whatever oil price regime materialises through 2030. ExxonMobil and Chevron lead on scale, ConocoPhillips on US shale, Occidental on the Permian and carbon capture, Petrobras on Brazilian deepwater. The portfolio slot that crypto cannot fill.

Passive ownership of global equities, tokenized. SPY and IVV both track the S&P 500 from different issuers, giving built-in tracking-variance diversification. QQQ adds NASDAQ-100 concentration. IEMG and EEM both track MSCI Emerging Markets across issuers. The simplest way to express 'I want the equity market' inside an on-chain portfolio.

Healthcare as the defensive ballast. Eli Lilly and Novo Nordisk capture the GLP-1 obesity drug cycle, the biggest pharma category since statins. UnitedHealth covers managed care, Pfizer holds legacy pharma, Moderna anchors the mRNA platform, and Hims & Hers represents direct-to-consumer pharmacy disruption. Low correlation to crypto and to mega-cap tech, which is the point.

Ten largest assets, capped at 20% per name. Balances Bitcoin and Ethereum dominance with HBAR (enterprise L1) and TRX (stablecoin rail) replacing the prior AVAX and SUI sleeves after the 2025 mid-cap drawdown. Sits between OCI6's concentration and OCI20's smart-beta tilt. The default 'diversified large-cap crypto' construction.

Twenty large to mid-cap assets weighted by the square root of market cap. The tilt overweights mid-caps versus a pure mcap index, which is the entire point. For allocators who want broader market participation without going equal-weight.

Half Bitcoin, half AI-and-blockchain infrastructure. TAO leads on subnet incentives, RENDER on GPU compute marketplaces, FET on agent infrastructure, GRT on indexing, NEAR on AI-native L1 work, IO on decentralized compute, AKT on cloud-compute marketplaces. A BTC-anchored construction that adds the AI narrative without giving up the Bitcoin core. For allocators who want pure-play AI exposure inside a basket already protected by Bitcoin dominance.

Twelve assets weighted via the Lopez de Prado HRP algorithm: assets cluster by correlation, then risk is allocated recursively down the tree so each branch carries equal contribution. BTC and ETH anchor the crypto cluster, ETHFI and PENDLE pick up restaking and yield exposure, ONDO and SKY cover the RWA leg, PAXG provides the gold sleeve, USDC absorbs the cash buffer. HRP avoids the matrix-inversion fragility of mean-variance while still respecting the correlation structure. The benchmark expression of modern multi-asset construction.